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Abstract The effects of deleting 1,3 and 15 amino acid residues 
from the highly conserved C-terminus of the tetrameric skeletal 
muscle ryanodine receptor (RyR) complex were determined. 
Immunoblot analysis indicated similar expression levels in 
HEK293 cells for full-length and mutant proteins. Full-length 
and RyR lacking the last amino acid showed [3H|ryanodine 
binding and single channel activities typical of native receptors. 
Deletion of 3 amino acids resulted in decreased activities, 
whereas deletion of 15 amino acids yielded an inactive RyR. 
These results suggest that the most 15 C-terminal amino acids 
are important for the expression of a functional RyR complex. 
© 1997 Federation of European Biochemical Societies. 
Key words: Ryanodine receptor; Ca 2 + release channel; 
Skeletal muscle; Excitation-contraction coupling 
1. Introduction 
The process of skeletal muscle contraction and relaxation 
involves rapid Ca 2 + release from the sarcoplasmic reticulum 
(SR) by the Ca 2 + release channel (ryanodine receptor, RyR) 
complex comprised of four 560-kDa (RyR polypeptide) and 
four 12-kDa (FK506-binding protein) subunits [1,2]. Analysis 
of the deduced amino acid sequence of rabbit skeletal muscle 
RyR polypeptide has suggested a large cytoplasmic N-termi-
nal 'foot' region, a membrane-spanning pore region, and a 
short ( ~ 1 0 0 amino acid residues) cytoplasmic C-terminus 
[3,4]. Studies with site directed antibodies have confirmed 
that the N and C termini of skeletal muscle RyR are cyto-
plasmically located [5,6] and moreover have shown that the C-
terminus is folded in an antibody-inaccessible conformation in 
the native receptor [6]. Sequence analysis of eight members of 
the RyR family has shown that the cytoplasmic C-terminal 
region is highly conserved [3,4,7-12] (Fig. 1). There are ten 
identical amino acids among the last fifteen residues, including 
the next to last one. Two members of the RyR family (Dro-
sophila, lobster) contain six additional C-terminal amino 
acids. These findings imply that C-terminal amino acids 
have a critical role in RyR function. 
In the present study, three C-terminal deletion forms of the 
skeletal muscle RyR missing 1, 3 and 15 amino acids (Al, A3 
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and A15 RyR, respectively) were prepared and expressed in 
human embryonic kidney (HEK293) cells. Expression of func-
tional tetrameric RyRs was assessed by sedimentation, 
[3H]ryanodine binding and single channel measurements. 
Our results suggest that the most 15 C-terminal amino acid 
residues are important for the expression of a functional skel-
etal muscle RyR complex. 
2. Materials and methods 
2.1. Materials 
Taq-polymerase, restriction endonucleases, other DNA modifying 
enzymes, and Pefabloc SC (a protease inhibitor) were purchased from 
Boehringer Mannheim. [3H]Ryanodine was obtained from Dupont 
NEN, unlabeled ryanodine and horseradish peroxidase-conjugated 
anti-rabbit and anti-mouse IgG antibodies from Calbiochem (La Jol-
la, CA), phospholipids from Avanti Polar Lipids (Birmingham, AL), 
and HEK293 cells from the Tissue Culture Facility of Lineberger 
Cancer Center at University of North Carolina. Expression vector 
pCMV5 was generously provided by Dr. David Russel (University 
of Texas Southwestern Medical Center, Dallas, TX). All other chem-
icals were of analytical grade. 
2.2. Construction of full-length and deletion mutant RyR cDNAs 
A full-length rabbit skeletal cDNA was prepared from three over-
lapping clones that were constructed from cDNA fragments in pBlue-
script vector using standard procedures. PBSL (Hin&WVXhol, 117 bp-
6596 bp) was obtained by preparing rabbit skeletal muscle mRNA 
and using the reverse transcription polymerase chain reaction with 
primers to the published rabbit skeletal muscle cDNA sequence [4]. 
PBSM (XhoVEcoRJ, 6597-11 766) was generously provided by Dr. 
Paul D. Allen (Brigham and Women's Hospital, Boston, MA). 
PBSR (£coRI///mdIII, 11767-15252) was obtained by screening a 
rabbit skeletal muscle cDNA library (Stratagene, La Jolla, CA) using 
an affinity-purified polyclonal antibody raised against the purified rat 
skeletal muscle RyR [13]. To construct the full-length cDNA, two 
subclones were initially prepared, using PBSL (HindlUKho), PBSM 
(XhollBamHl, 6597-11 113) and pCMV5 (Hind UllBamHl) for pre-
paring pCMV5L+M, and pCMV5 (EcoRVHindlU) and PBSR 
(EcoRVHindlU) for preparing pCMV5R. Full-length RyR cDNA 
was obtained by the ligation of four restriction site fragments: Gall 
Xhol from pCMV5L+M, XhollEcoRl from PBSM, EcoRUXbal from 
pCMV5R, and ClaVXbal from pCMV5 vector. C-Terminal deletions 
were made by polymerase chain reaction amplification of 804 C-ter-
minal bases of PBSR (C/al/TGA), using three primers that resulted in 
the loss of three, nine, and 45 bases of the C-terminal sequence encod-
ing the skeletal muscle RyR. The amplified fragments were inserted 
into pBluescript vector (Clal/Smal) to generate three new subclones: 
A1PBS, A3PBS, and A15PBS. These were used to construct 
DlpCMV5R, D3pCMV5R and D15pCMV5R, and subsequently the 
final deletion mutant RyR cDNAs. 
2.3. Expression of full-length and mutant RyRs 
RyR cDNAs cloned into pCMV5 were transiently expressed in 
HEK293 cells using the Lipofectamine (GIBCO BRL, Grand Island, 
NY) method according to the manufacturer's instructions. Cells were 
maintained in DMEM-H containing 10% fetal bovine serum and 20 
mM HEPES, pH 7.3 at 37°C in 5% C0 2 and plated the day before 
transfection. For each 10 cm tissue culture dish, 8 ug DNA was used 
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at a DNA/Lipofectamine ratio of 1/3 to 1/5. Cells were harvested 42-
46 h after transfection SR 
2.4. Preparation of membrane fraction 
Cells were grown on 10 cm tissue culture dishes, washed twice with 
4 ml ice-cold PBS containing 5 mM EDTA and protease inhibitors 
(0.2 mM Pefabloc, 100 nM aprotinin, 50 uM leupeptin, 1 U.M pep-
statin, and 1 mM benzamidine), and harvested in the same solution by 
removal from plates by scraping. Cells were collected by centrifuga-
tion at 3500 rpm for 10 min in a RC3B centrifuge, resuspended in the 
above solution without EDTA, and pelleted again. A membrane frac-
tion was prepared as described [14] with some modification. Briefly, 
cell homogenates were centrifuged for 1 h at 35 000 rpm in a Beckman 
Ti50 rotor, and pellets were resuspended in a buffer containing 25 mM 
Tris-HEPES, pH 7.4, 0.3 M sucrose, 0.15 M KC1, 20 uM CaCl2 and 
above protease inhibitors, and stored at —80°C. 
2.5. Electrophoresis and Western blotting 
Proteins were denatured for 5 min at 95-100°C and separated on 3 -
12% SDS polyacrylamide gels [15]. Proteins were transferred to Im-
mobilon-P membranes at 4°C at 400 mA for 1-3 h followed by 1 A 
for 14-16 h. Membranes were blocked for 1 h at room temperature 
with 5% non-fat dry milk and 0.1% Tween 20 in PBS, and incubated 
for 3 h at room temperature with a monoclonal antibody specific for 
skeletal muscle RyR (RyRDllO, unpublished studies) in PBS contain-
ing 1% non-fat dry milk and 0.1% Tween 20. After washing, the 
bound antibody was detected with horseradish peroxidase-conjugated 
anti-mouse IgG using 3,3-diaminobenzidine and H2O2. 
2.6. Isolation and reconstitution of expressed RyRs 
RyRs from two culture dishes were solubilized for 10 min at room 
temperature in 1.5 ml of a buffer containing 5 mg/ml phosphatidyl-
choline and 1.45%) CHAPS and isolated by rate density centrifugation 
[16]. To detect RyRs on the gradients, solubilized RyRs were labeled 
with 20 nM [3H]ryanodine for 1 h at room temperature in the absence 
and presence of 20 |iM unlabeled ryanodine. For Western blot anal-
ysis, RyRs were sedimented by centrifuging gradient fractions for 20 h 
at 45000 rpm in a Beckman Ti75 rotor at 0°C. For single channel 
measurements, pooled RyR gradient peak fractions were reconstituted 
into proteoliposomes by removal of CHAPS by dialysis [17]. 
2.7. [3HJ'Ryanodine binding 
Membranes of 1/5 culture dish were incubated with [3H]ryanodine 
at room temperature in 100 ul of a buffer containing 20 mM Tris-
HEPES, pH 7.4, 0.6 M KC1, 0.15 M sucrose, 5 mM AMP, 310 uM 
Ca2+, 200 uM EGTA (110 uM free Ca2+), 0.2 mM Pefabloc, and 10 
uM leupeptin. Non-specific binding was determined using a 1000-fold 
excess of unlabeled ryanodine. After 4 h, aliquots of the samples were 
diluted with 20 volumes of ice-cold water and placed on Whatman 
GF/B filters preincubated with 2% polyethyleneimine in water. Filters 
were washed with 3X5 ml ice-cold 0.1 M KC1, 1 mM KPIPES, pH 
7.0. The radioactivity remaining with the filters was determined by 
liquid scintillation counting to obtain bound [3H]ryanodine. 
2.8. Single channel recordings 
Single channel measurements were performed by incorporating ex-
pressed RyR channels in Mueller-Rudin-type lipid bilayers [18]. Pro-
teoliposomes containing the expressed RyRs were added to the cis 
chamber of a bilayer apparatus and fused in the presence of an os-
motic gradient (350 mM cis KC1/20 mM trans-KCl in 10 mM 
KHEPES, pH 7.3) with planar bilayers containing a 4:1 mixture of 
bovine brain phosphatidylethanolamine and phosphatidylcholine (50 
mg of total phospholipid/ml of «-decane). After appearance of chan-
nel activity, further fusion of proteoliposomes was prevented by in-
creasing trans-[KCi\ to 0.35 M. The trans side of the bilayer was 
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Fig. 2. Expression of full-length and truncated RyRs in HEK293 
cells. Transfected cells were incubated with Laemmli SDS sample 
buffer for 5 min at 95-100°C and separated by 3-12% SDS-PAGE. 
Ryanodine receptor proteins were detected on immunoblots using 
monoclonal antibody RyRDllO. 
defined as ground. Electrical signals were filtered at 4 kHz, digitized 
at 20 kHz, and analyzed as described [18]. 
3. Results and discussion 
3.1. Expression of RyR cDNAs in HEK293 cells 
The expression plasmid pCMV5RyR encoding the entire 
skeletal muscle RyR protein sequence was constructed and 
used to transfect HEK293 cells. Similarly, three truncated 
forms were constructed and expressed in HEK293 cells. In 
agreement with previous studies [14,19,20], full-length cDNA 
could be also expressed in CHO and COS cells, although with 
lower levels than in HEK293 cells. Transient expression of 
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Fig. 1. Aligment of C-terminal amino acids of ryanodine receptors. 
Fig. 3. [3H]Ryanodine binding to full-length and truncated RyRs. 
Membranes of 1/5 cell culture dish were incubated with 0.5-16 nM 
[3H]ryanodine for 4 h at room temperature as described in Methods 
(see Section 2). Scatchard analysis of [3H]ryanodine binding yielded 
the following averaged (±S.D.) 5 m a x (pmol/dish) and Kd (nM) val-
ues, respectively (« = 3): Full-length RyR: 0.11 ±0.06, 2.9±0.3; 
AIRyR: 0.13 ±0.10, 2.3 ±1.5; A3RyR: 0.03 ±0.01, 2.7 ±1.0; A15 
RyR: No specific [3H]ryanodine binding was detected for cells 
transfected with A15 RyR cDNA. 
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RyR was detected by immunoblotting using mAb RyRDllO 
raised against rabbit skeletal muscle RyR (Fig. 2). In cells 
transfected with full-length and truncated cDNAs, there was 
a major high molecular weight protein band corresponding to 
rabbit skeletal muscle 560-kDa RyR polypeptide, whereas 
only background staining was observed in the control (vector 
only) lane. In addition, several lower molecular weight bands 
were present. These likely represent degradation products of 
the expressed RyRs, since they were absent in the control 
lane. Densitometry of blots indicated that full-length and 
truncated RyRs were expressed at similar levels in HEK293 
cells. 
3.2. [3 H]Ryanodine binding to membranes 
Possible differences in the function of the expressed deletion 
mutants were investigated by determining the [3H]ryanodine-
binding properties of cell membrane fractions and by carrying 
out single channel measurements. Scatchard analysis of 
[3H]ryanodine-binding data indicated the presence of a single 
high-affinity [3H]ryanodine-binding site with similar affinities 
for the full-length, Al and A3 constructs (Fig. 3). Membranes 
of cells transfected with full-length and Al RyR cDNAs had a 
similar Bmax value of specific [
3H]ryanodine binding. Lower 
levels of [3H]ryanodine binding were observed in membranes 
obtained from cells transfected with A3 RyR cDNA, whereas 
no specific [3H]ryanodine binding could be detected in cells 
transfected with A15 RyR cDNA (not shown). The observa-
tion of different [3H]ryanodine-binding levels was further pur-
sued by determining the sedimentation behavior of CHAPS-
solubilized, [3H]ryanodine-labeled RyRs [16]. A single peak of 
bound [3H]-radioactivity with a sedimentation value of 30 S 
was apparent when cells were transfected with full-length and 
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Fig. 4. [3H]Ryanodine-binding sedimentation profile of CHAPS-
solubilized, transfected cells centrifuged through a linear sucrose 
density gradient. Cells from two culture dishes were incubated for 
1 h at room temperature in 1.5 ml of a solubilizing solution con-
taining 5 mg/ml PC, 1.45% CHAPS and 20 nM [3H]ryanodine and 
then centrifuged through a 7-20% linear sucrose gradient as de-
scribed in Methods. Gradient fractions (labeled from bottom to 
top) were analyzed for [3H]-radioactivity. A similar [3H]-radioactiv-
ity profile was obtained when CHAPS-solubilized heavy SR vesicles 
were centrifuged through a parallel gradient, indicating presence of 
tetrameric 30 S RyR complexes [16] in gradient fraction 4. 
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Fig. 5. Single channel activities of full-length and truncated RyRs. 
Expressed full-length RyR (left panel), Al RyR (right panel) and A3 
RyR (bottom trace) were purified, reconstituted in lipid bilayer 
vesicles, and incorporated into planar lipid bilayers. Single channel 
currents, shown as downward deflections (RyR and Al RyR) from 
closed level (- -), were recorded in symmetrical 0.35 M KC1, 10 mM 
KHEPES, pH 7.3 media containing 20 uM free Ca2+ (top traces) 
and following the successive addition of EGTA (second traces), 
Ca2+ and ATP (third traces) and Mg2+ (fourth traces) to the cis 
(SR cytosolic) side of the bilayer chamber to yield the indicated 
concentrations. The left fifth trace is from a separate experiment ob-
tained after the addition of 2 |xM ryanodine to the cis chamber. 
Holding potential was —40 mV. Right panel traces were obtained 
from a bilayer in which 4 Al RyRs had been incorporated. P„ val-
ues of left and right panels were as follows: 0.09 and 0.12 (first 
traces), ~0 and 0.001 (second traces), 0.53 and 0.85 (third traces), 
and 0.005 and 0.04 (fourth traces). The bottom trace shows a re-
cording of A3 RyR in 0.35 M cytosolic/0.02 M luminal KC1, 10 
mM KHEPES, pH 7.3 medium containing 20 uM free Ca2+. The 
holding potential was +40 mV. Current deflections are upward. 
Al and A3 RyR cDNAs (Fig. 4). In agreement with data of 
Fig. 3, cells transfected with A3 RyR cDNA showed a de-
creased level of bound [3H]ryanodine. Cells transfected with 
A15 RyR cDNA did not exhibit a peak of bound [3H]-radio-
activity. The presence of RyRs in gradient fractions was also 
tested using a monoclonal antibody to the skeletal muscle 
RyR. Immunoblots showed the presence of a 560-kDa RyR 
protein band in gradient fraction 4 (see Fig. 4) for all trans-
fected cells and variable amounts of the 560-kDa band as well 
as lower molecular weight immunoreactive material in the top 
gradient fractions (Fractions 6-8) (not shown). In gradient 
fractions 7 and 8, the highest levels of the 560-kDa band 
were seen in cells transfected with A15 RyR cDNAs. Predom-
inant presence of lower molecular protein bands indicated an 
increased sensitivity of the A3 RyR to proteolysis. These re-
sults suggest that deletion of C-terminal amino acids impairs 
the assembly of a tetrameric RyR channel complex. Another 
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possibility is the formation of an incorrectly folded receptor 
complex that is more readily dissociated into its monomeric 
subunits by detergents [21]. 
3.3. Single channel measurements 
Channel activity of expressed and purified RyRs was re-
corded in symmetrical 0.35 M KC1 medium with different 
additions in the cis (SR cytosolic) bilayer chamber. In 350 
mM symmetrical KC1 solution, full-length and Al RyR chan-
nels had a mean conductance of 792 ± 10 pS (±S.D., « = 6) 
and 764 ±40 pS (« = 5), respectively, which was essentially 
identical to that of native RyR (not shown). In 20 uM cis 
(SR cytosolic) Ca2+, channel activities were comparable to 
those of native RyR (Fig. 5 left and right panels, top traces). 
The mean channel open probabilities (P0s) were 0.16 ±0.18 
(±S.D., n = 5) and 0.30 ±0.15 (« = 3), respectively, for full-
length and Al RyRs. Reducing cis Ca2+ to ~ 7 0 nM by add-
ing EGTA to the cis chamber decreased channel activities to 
near zero (Fig. 5, second traces). Po increased to 0.71 ± 0.07 
(n = 4) and 0.85 (n = 2) (Fig. 5, third traces) when cis Ca2+ was 
raised to ~ 5 (0.M and millimolar ATP was added to the cis 
chamber. Further addition of 10 mM Mg2+ reduced channel 
activities to 0.009 ±0.008 (« = 3) and 0.02 (« = 2) (Fig. 5, 
fourth traces). In separate experiments, addition of 10 \xM 
ruthenium red completely abolished channel activities (data 
not shown). Addition of 2 |a.M ryanodine to the cis side locked 
the expressed full-length channel in a sub-conductance state 
(Fig. 5 left panel, fifth trace). Thus, the expressed skeletal 
muscle full-length and Al RyRs exhibited a conductance 
and pharmacology indistinguishable from that of native re-
ceptors. 
A3 RyR showed a single channel activity with a conduc-
tance (~740 pS) resembling that of full-length channels in 
two out of a total of five experiments (Fig. 5C). In both cases, 
channels disappeared too quickly (<3 s) to allow determina-
tion of their pharmacology. These results suggest that removal 
of the 3 C-terminal amino acids from the skeletal muscle RyR 
polypeptide does not affect channel conductance but has seri-
ous deleterious effects on channel stability in lipid bilayers. No 
A15 RyR single channel activity resembling that of native or 
expressed full-length RyR was observed in five experiments. 
In conclusion, three truncated RyR cDNAs were used to 
show that the most C-terminal 15 amino acids play an im-
portant role in the assembly of skeletal muscle RyR capable 
of [3H]ryanodine binding and displaying a stable channel ac-
tivity in lipid bilayers. 
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